![]() |
市場調查報告書
商品編碼
2032625
光遺傳學市場報告:照明設備按類型、應用、最終用戶和地區分類(2026-2034 年)Optogenetics Market Report by Light Equipment Type (Light-emitting Diode, Laser), Application, End User, and Region 2026-2034 |
||||||
2025年全球光遺傳學市場規模達586億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到1,811億美元,2026年至2034年的複合年成長率(CAGR)為12.95% 。成長要素包括光遺傳學技術的顯著進步、神經系統疾病盛行率的上升、對精準醫療需求的成長,以及公共和私人機構在研發活動方面的大量投資。
光遺傳學是指結合遺傳學和光學技術的科學方法。它主要利用光學感測器來控制和監測神經元及其他細胞的生物功能。這些資訊有助於深入了解個體的行為和生理功能,包括運動、學習、記憶、導航、新陳代謝、呼吸和感覺處理。光遺傳學透過闡明與多種疾病相關的細胞活動,為臨床發現做出貢獻,例如慢性疼痛、癲癇、帕金森氏症、中風、藥物成癮、強迫症(OCD)、社交功能障礙、焦慮和憂鬱症。由於這些應用領域,光遺傳學在神經科學領域得到了廣泛應用。
各種感染疾病、疾病、遺傳性疾病、先天缺陷以及由腦、神經和脊髓損傷引起的神經系統疾病的日益普遍,是目前光遺傳學市場成長的主要驅動力之一。光纖耦合發光二極體(LED)的引入,使得透過植入進行無線光傳輸成為可能,這也是另一個重要的成長促進因素。此外,神經連接、無線微晶片、感測器、細胞表現型分析工具以及各種成像診斷工具(例如電腦斷層掃描(CT)、正子斷層掃描(PET)和磁振造影(MRI))的快速技術進步,使得對器官和組織進行精確評估以識別疾病成為可能,從而進一步促進了市場成長。由於光遺傳學療法在細胞、空間和時間層面具有很高的精確度,醫療專業人員擴大採用該治療方法,這也促進了市場成長。其他促成市場前景樂觀的因素包括醫療保健支出增加、神經科學領域廣泛的研發活動,以及領先企業、製藥公司和政府之間為實施有利於推出治療神經系統疾病新藥的政策而建立的戰略聯盟。
也研究了該行業的競爭格局,重點公司包括 Addgene、Coherent Inc.、Elliot Scientific 檢驗、GenSight Biologics SA、HUBNER GmbH & Co KG、Judges Scientific plc、Laserglow Technologies、Noldus Information Technology、Regenxbio Inc.、上海雷射光學世紀有限公司、傑克遜光學和 Thorlabs。
The global optogenetics market size reached USD 58.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 181.1 Billion by 2034, exhibiting a growth rate (CAGR) of 12.95% during 2026-2034. The market is primarily driven by the notable developments in optogenetics technology, rising incidence of neurological illnesses, growing need for precision medicine, and substantial investment by public and private organizations in research and development activities.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.
This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. The report categorizes the market based on light equipment type, application and end user.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HUBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.